SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

21 Apr 2009 07:00

RNS Number : 8645Q
CVS Group plc
21 April 2009
 



For Immediate Release

21 April 2009

CVS Group plc

("CVS" or the "Company")

Acquisition of Earls Hall Veterinary Group ("Earls Hall")

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Earls Hall, a tier three animal hospital with 3 further branches based in Southend. This acquisition will further strengthen the Company's existing presence in the geographical area and brings the total number of Group surgeries to 168.  

CVS will assume all management responsibilities for Earls Hall following completion of the acquisition including the current employees, which comprise nine professional vets amongst a total staff of 43. In line with CVS' strategy, administration will be consolidated within the Company's central facilities, providing scope for cost synergies and benefits following the acquisition.

In the year ended 30 April 2008 Earls Hall achieved profit before tax of £150,000 on turnover of £1.919 million and its fixed assets were £80,000 at the period end. The consideration for the acquisition is being met entirely from internal cash generation.

Commenting on the acquisition, CVS Chief Executive Simon Innes said "Earls Hall is a large well established practice with a highly regarded team of dedicated professionals and a loyal client following. We look forward to working with them, allowing Earls Hall to concentrate on continuing to provide clinical excellence and client services."

Contacts

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Buchanan Communications

Richard Oldworth

Ben Romney 

 

020 7466 5000

Panmure Gordon

Richard Gray

Andrew Godber

020 7459 3600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQILFLRSFIIFIA
Date   Source Headline
27th Nov 20088:32 amRNSHolding(s) in Company
24th Nov 20081:51 pmRNSHolding(s) in Company
20th Nov 20082:10 pmRNSLTIP Award
14th Nov 20081:03 pmRNSAnnual Report and Accounts
14th Nov 20087:00 amRNSAcquisition
29th Oct 200810:44 amRNSHolding(s) in Company
27th Oct 20084:45 pmRNSSecond Price Monitoring Extn
27th Oct 20084:38 pmRNSPrice Monitoring Extension
7th Oct 20087:00 amRNSAcquisition
19th Sep 200812:27 pmRNSHolding(s) in Company
16th Sep 20087:00 amRNSPreliminary Results
1st Sep 20087:00 amRNSShareSave Scheme
28th Aug 200810:48 amRNSHolding(s) in Company
5th Aug 20089:25 amRNSHolding(s) in Company
17th Jul 20087:00 amRNSHolding(s) in Company
8th Jul 20087:00 amRNSPre-Close Trading Update
7th Jul 20082:26 pmRNSHolding(s) in Company
12th May 20084:40 pmRNSNotifiable Shareholding
25th Apr 20086:04 pmRNSHolding(s) in Company
2nd Apr 20085:28 pmRNSDirector/PDMR Shareholding
26th Mar 20082:22 pmRNSHolding(s) in Company
25th Mar 20089:50 amRNSHolding(s) in Company
18th Mar 20087:02 amRNSAcquisition
18th Mar 20087:01 amRNSInterim Results
26th Feb 20087:01 amRNSAcquisition
18th Feb 20084:00 pmRNSNotice of Results
21st Jan 20084:33 pmRNSHolding(s) in Company
14th Jan 20081:55 pmRNSHolding(s) in Company
10th Jan 20087:00 amRNSAcquisition
13th Dec 20077:01 amRNSAcquisitions/Trading Update
12th Dec 20073:27 pmRNSHolding(s) in Company
12th Dec 200711:35 amRNSHolding(s) in Company
28th Nov 20077:01 amRNSAcquisition
20th Nov 20076:39 pmRNSHolding(s) in Company
8th Nov 200710:37 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
10th Oct 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.